Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2006-06-13
2006-06-13
Horlick, Kenneth R. (Department: 1637)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091200
Reexamination Certificate
active
07060438
ABSTRACT:
A patient's genetic predisposition to a disease may be analyzed by placing, in the presence of probes, at least one type of amplicon, derived from the amplification of at least one polymorphic region of nucleic acid from the patient. The polymorphic region is a polymorphic region of interest with respect to the disease(s) being sought. The probes include at least one specific “low-resolution” typing probe that has the ability to hybridize to the polymorphic region of interest of at least one gene or a group of alleles of this gene carried by the amplicon and associated with the disease(s); and at least one specific “high-resolution” subtyping probe that has the ability to hybridize to the polymorphic region of interest of the allele or of the group of alleles specific for the “low-resolution” typing probe, the high-resolution probe(s) making it possible to distinguish the allele(s) associated with susceptibility and/or the allele(s) associated with resistance to the disease(s), according to whether or not they hybridize.
REFERENCES:
patent: 5468611 (1995-11-01), Baxter-Lowe et al.
patent: 5567809 (1996-10-01), Apple et al.
patent: 5939542 (1999-08-01), Kawai et al.
patent: 5976789 (1999-11-01), Allibert et al.
patent: 717296 (1996-12-01), None
patent: 0 875 582 (1998-11-01), None
patent: 0 887 423 (1998-12-01), None
patent: 2679252 (1993-01-01), None
patent: A 6-90757 (1994-04-01), None
patent: A 8-308596 (1996-11-01), None
patent: WO 92/08117 (1992-05-01), None
patent: WO 97/20070 (1997-06-01), None
patent: WO 97/46700 (1997-12-01), None
patent: WO 98/35059 (1998-08-01), None
patent: WO 99/07883 (1999-02-01), None
patent: WO 99/19509 (1999-04-01), None
Begovich et al. A specific HLA-DP beta allel is associated with pauciarticular juvenile rheumatoid arthritis but not adult rheumatoid arthritis. PNAS, vol. 86, pp. 9489-9493, Dec. 1989.
Scharf et al. Specific HLA-DQB and HLA-DRB1 alleles confer susceptibility to pemphigus vulgaris. PNAS, vol. 86, pp. 6215-6219, Aug. 1989.
Evans, et al. The Genotype Distribution of Shared-epitope DRB1 alleles suggest a recessive mode of inheritance of the rheumatoid arthritis disease-susceptibility gene. Arthritis and Rheumatism. vol. 38, pp. 1754-1761, 1995.
Kawai et al. A simple method of HLA-DRB typing using enzymatically amplified DNA and immobilized probes on microtiter plate. Human Immunology, vol. 41, pp. 121-126, 1991.
Weyand et al. Correlation betwen Disease pphenotype and genetic heterogeneity in Rheumatoid Arthritis. The Journal of Clinical Investigation, Inc. vol. 95, vol. 2120-2126, May 1995.
Garcia-Pacheco et al. “Routine HLA DRB/DQB oligonucleotide typing by a non-radioactive dot-blot micromethod”, Journal of Immunological Methods 180 (1995) 35-43.
Bein et al., “Rapid HLA-DRB1 genotyping by nested PCR amplification”, Tissue Antigens 1992: 39: 68-73, XP-000949259.
Kim et al., “Predominance of HLA-DRB1*0405 in Korean patients with rheumatoid arthritis”, Annals of the Rheumatic Diseases 1995; 54: 988-990, XP-000878854.
Kawai et al., A Simple Method of HLA-DRB Typing Using Enzymatically Amplified DNA and Immobilized Probes on Microtiter Plate, Human Immunology 41, 121-126 (1994), XP-000890112.
Evans et al., “The Genotypic Distribution of Shared-Epitope DRB1 Alleles Suggests A Recessive Mode of Inheritance Of The Rheumatoid Arthritis Disease-Susceptibility Gene”, Arthritis & Rhuematism, vol. 38, No. 12, Dec. 1995, pp. 1754-1761, XP-000878857.
XP-002133035, Derwent Publications Ltd., “Detection and typing of class I MHC HLA-DR antigens—can check multiple specimens easily and type all HLA-DR (D-related) antigens known to be present in the Japanese population”.
Allen et al. “Allele-Specific HLA-DRB1 Amplification of Forensic Evidence Samples with Mixed Genotypes”, BioTechniques, vol. 19, No. 3 (1995), XP-002133033.
XP-002133036, Derwent Publications Ltd., “Oligo:nucleotide probes for HLA-DR typing of human DNA—and reagent kits containing probes, new amplification primers and buffers”.
Petersdorf et al., “Polymorphism of HLA-DRw52-associated DRB1 genes as defined by sequence-specific oligonucleotide probe hybridization and sequencing”, Tissue Antigens, vol. 38, No. 4, Oct. 1, 1991, pp. 169-177, XP000673021.
Haworth et al., Polymyalgia Rheumatica Is Associated With Both HLA-DRB1*0401 and DRB1*0404, British Journal of Rheumatology 1996; 35:632-635, XP-000878853.
Takeuchi et al., “Positive and negative association of HLA-DR genotypes with Japanese rheumatoid arthritis”, Clinical and Experimental Rheumatology 14: 17-22, 1996., XP-000878869.
Nepom et al., “HLA Genes Associated With Rheumatoid Arthritis” Arthritis and Rheumatism, vol. 32, No. 1 (Jan. 1989), XP-000879219.
Wagner et al., “HLA Markers And Prediction Of Clinical Course And Outcome In Rheumatoid Arthritis”, Arthritis & Rheumatism, vol. 40, No. 2. Feb. 1997, pp. 341-351, XP-000878856.
Gao et al., DNA Typing for Class II HLA Antigens with Allele-Specific of Group-Specific Amplification, Human Immunology, vol. 30, 1991, pp. 147-154, XP-000889911.
Cereb et al., “Locus-specific amplification of HLA class I from genomic DNA: locus-specific sequences in the first and third introns of HLA-A, -B, and -C alleles”, Tissue Antigens, vol. 45, 1995, pp. 1-11, XP-000197333.
Angelini et al. “High-resolution analysis of the human HLA-DR polymorphism by hybridization with sequence-specific oligonucleotide probes”, Proceedings of the National Academy of Sciences, vol. 83, 1986, pp. 4489-4493, XP-002133034.
Wordsworth et al., “HLA-DR typing using DNA amplification by the polymerase chain reaction and sequential hybridization of sequence-specific oligonucleotide probes”, Immunogenetics, vol. 32, Jan. 1, 1990, pp. 413-418, XP-002911048.
Nepom et al., “MHC Class-II Molecules And Autoimmunity”, Annu. Rev. Immunol. 1991. 9:493-525.
Weiss et al., “Organization, Sequence and Expression of the HLA-B27 Gene: A Molecular Approach to Analyze HLA and Disease Associations”, Immunobiol., vol. 170, pp. 367-380 (1985).
Lawrence, “Rheumatoid Arthritis—Nature or Nurture?”, Ann. Rheum, Dis. (1970), 29, 357.
Stastny et al. “HLA-DR4 And Other Genetic Markers In Rheumatoid Arthritis”, British Journal of Rheumatology, 1988; 27 (suppl II): 132-138.
Baarsma “The epidemiology and genetics of endogenous uveitis: a review”, Current Eye Research, vol. 11, supplement 1992, 1-9.
Stastny et al. “The Human Immune Response Region (HLA-D) and Disease Susceptibility”, Immunological Rev. (1983), vol. 70.
Benjamin et al., “Guilt by association: HLA-B27 and ankylosing spondylitis” Immunology Today, vol. 11, No. 4 1990.
The Lancet, Apr. 28, 1979, pp. 921-922.
Todd et al., “A Molecular Basis for MHC Class II-Associated Autoimmunity”, Science, vol. 240.
Wordsworth et al., “HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region”, Proc. Natl. Acad. Sci, vol. 86, 99. 10049-10053, Dec. 1989, Immunology.
Gregersen et al., “Molecular diversity of HLA-DR4 haplotypes”, Proc. Natl. Acad. Sci., vol. 83, pp. 2642-2646, Apr. 1986, Immunology.
Hiraiwa et al., “Structural requirements for recognition of the HLA-Dw14 class II epitope: A key HLA determinant associated with rheumatoid arthritis”, Proc. Natl. Acad. Sci, vol. 87, pp. 8051-8055, Oct. 1990, Immunology.
Hill et al., “HLA class 1 typing by PCR: HLA-B27 and an African B27 subtype”, The Lancet, vol. 337; Mar. 16, 1991.
The Lancet, Apr. 28, 1973, pp. 904-9073.
Schlosstein et al., “High Association Of An HL-A Antigen, W27, With Ankylosing Spondylitis”, The New England Journal of Medicine, Apr. 5, 1973.
Stastny, “Association Of The B-Cell Alloantigen DRw4 With Rheumatoid Arth
Mougin Bruno
Tiercy Jean-Marie
Bio Merieux
Horlick Kenneth R.
Oliff & Berridg,e PLC
LandOfFree
Method for analyzing a patient's genetic prediposition to at... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for analyzing a patient's genetic prediposition to at..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for analyzing a patient's genetic prediposition to at... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3663634